CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- 4 Open-market sale 10% owner sold 2,829,314 shares at an average $0.53 ($1,488,844)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,850 shares at $1.30 ($3,705)
- 4 Open-market sale Brazzell Romulus K sold 3,504 shares at $1.30 ($4,555)
- 4 Open-market sale Bazemore Todd sold 3,454 shares at $1.30 ($4,490)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 9,518 shares at $1.30 ($12,373)
- 4 Open-market sale Trachtenberg Eric sold 2,850 shares at $1.30 ($3,705)
- 4 Grant or award CHIEF BUSINESS OFFICER acquired 295,657 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,341,120 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 30,500 shares at an average $1.81 ($55,321)
- 4 Open-market sale Trachtenberg Eric sold 9,449 shares at $1.80 ($17,008)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 9,449 shares at $1.80 ($17,008)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 12,544 shares at $1.80 ($22,579)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 12,757 shares at $1.80 ($22,963)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 27,598 shares at $1.80 ($49,676)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 5,548 shares at $5.56 ($30,847)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 2,452 shares at $5.77 ($14,148)
Page 7 of 15 · 288 filings